{"id":"NCT00080288","sponsor":"Cephalon","briefTitle":"Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD","officialTitle":"A 12 Week, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CEP 10953 (150 mg) as Treatment for Adults With Excessive Sleepiness Associated With Chronic Shift Work Sleep Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-03","primaryCompletion":null,"completion":"2004-12","firstPosted":"2004-03-29","resultsPosted":"2009-09-23","lastUpdate":"2013-07-19"},"enrollment":254,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Excessive Sleepiness","Shift Work Sleep Disorder"],"interventions":[{"type":"DRUG","name":"Armodafinil 150 mg/day","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to determine whether treatment with Armodafinil (CEP-10953) is more effective than placebo treatment for patients with excessive sleepiness associated with chronic shift work sleep disorder (SWSD) by measuring mean sleep latency from the Multiple Sleep Latency Test (MSLT) (20 minutes) (average of 4 naps at 0200, 0400, 0600, and 0800) and by Clinical Global Impression of Change (CGI-C) ratings.","primaryOutcome":{"measure":"Multiple Sleep Latency Test (MSLT)","timeFrame":"up to 12 weeks","effectByArm":[{"arm":"Armodafinil 150 mg/Day","deltaMin":3.1,"sd":4.46},{"arm":"Placebo","deltaMin":0.4,"sd":2.87}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":11},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19880686"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":123},"commonTop":["Headache","Nausea","Nasopharyngitis"]}}